Skip to content

Investigating the Role of Brain-derived Neurotrophic Factor (BDNF) Between Pain and Other Neuronal Disease

Investigating the Role of Brain-derived Neurotrophic Factor (BDNF) Between Pain and Other Neuronal Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03606915
Enrollment
131
Registered
2018-07-31
Start date
2015-07-10
Completion date
2019-12-31
Last updated
2020-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

pain

Brief summary

Measure the cytokines, transforming or neurotrophic factors in CSF and plasma as the pain markers and as a new therapeutic target for pain control.

Detailed description

The research protocol was approved by the Institutional Review Board (IRB) for the Protection of Human Subjects at National Cheng Kung University Hospital (NCKUH/B-ER-104-070). The study procedures were performed according to the rules of IRB and fully explained to the participants. Blood and CSF samples were collected and compared the difference in no pain group, acute pain group, and chronic pain group.

Interventions

BEHAVIORALpain evaluation

collect CSF during spinal anesthesia

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* . Patients undergo spinal anesthesia * . Over 20 years of age * Patients who are competent to understand the study and provide written informed consent.

Exclusion criteria

* Patients have the contraindication for spinal anesthesia (refuse spinal anesthesia, coagulopathy, severe aortic stenosis) * Refuse participated in this study or pre-existent neurological disease. * Patients with advanced tumor staging (stage 3 or 4).

Design outcomes

Primary

MeasureTime frameDescription
cytokine measurement in cerebrospinal fluidthrough study completion, an average of 1 yearcytokine measurement ( via ELISA) in cerebrospinal fluid
cytokine measurement in bloodthrough study completion, an average of 1 yearcytokine measurement (via ELISA) in blood

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026